These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 15221989

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The loss of miR-26a-mediated post-transcriptional regulation of cyclin E2 in pancreatic cancer cell proliferation and decreased patient survival.
    Deng J, He M, Chen L, Chen C, Zheng J, Cai Z.
    PLoS One; 2013; 8(10):e76450. PubMed ID: 24116110
    [Abstract] [Full Text] [Related]

  • 23. Human pancreatic adenocarcinomas express parathyroid hormone-related protein.
    Bouvet M, Nardin SR, Burton DW, Behling C, Carethers JM, Moossa AR, Deftos LJ.
    J Clin Endocrinol Metab; 2001 Jan; 86(1):310-6. PubMed ID: 11232017
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
    Von Marschall Z, Scholz A, Stacker SA, Achen MG, Jackson DG, Alves F, Schirner M, Haberey M, Thierauch KH, Wiedenmann B, Rosewicz S.
    Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
    [Abstract] [Full Text] [Related]

  • 28. Establishment of perineural invasion models and analysis of gene expression revealed an invariant chain (CD74) as a possible molecule involved in perineural invasion in pancreatic cancer.
    Koide N, Yamada T, Shibata R, Mori T, Fukuma M, Yamazaki K, Aiura K, Shimazu M, Hirohashi S, Nimura Y, Sakamoto M.
    Clin Cancer Res; 2006 Apr 15; 12(8):2419-26. PubMed ID: 16638847
    [Abstract] [Full Text] [Related]

  • 29. The expression of S100A4 in human pancreatic cancer is associated with invasion.
    Tsukamoto N, Egawa S, Akada M, Abe K, Saiki Y, Kaneko N, Yokoyama S, Shima K, Yamamura A, Motoi F, Abe H, Hayashi H, Ishida K, Moriya T, Tabata T, Kondo E, Kanai N, Gu Z, Sunamura M, Unno M, Horii A.
    Pancreas; 2013 Aug 15; 42(6):1027-33. PubMed ID: 23851436
    [Abstract] [Full Text] [Related]

  • 30. The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer.
    He H, Di Y, Liang M, Yang F, Yao L, Hao S, Li J, Jiang Y, Jin C, Fu D.
    Oncol Rep; 2013 Aug 15; 30(2):651-8. PubMed ID: 23733161
    [Abstract] [Full Text] [Related]

  • 31. Epidermal growth factor induces cyclin D1 in human pancreatic carcinoma: evidence for a cyclin D1-dependent cell cycle progression.
    Poch B, Gansauge F, Schwarz A, Seufferlein T, Schnelldorfer T, Ramadani M, Beger HG, Gansauge S.
    Pancreas; 2001 Oct 15; 23(3):280-7. PubMed ID: 11590324
    [Abstract] [Full Text] [Related]

  • 32. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
    Piao J, Liu S, Xu Y, Wang C, Lin Z, Qin Y, Liu S.
    Exp Mol Pathol; 2015 Feb 15; 98(1):1-6. PubMed ID: 25445504
    [Abstract] [Full Text] [Related]

  • 33. Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma.
    Nagao Y, Hisaoka M, Matsuyama A, Kanemitsu S, Hamada T, Fukuyama T, Nakano R, Uchiyama A, Kawamoto M, Yamaguchi K, Hashimoto H.
    Mod Pathol; 2012 Jan 15; 25(1):112-21. PubMed ID: 21983937
    [Abstract] [Full Text] [Related]

  • 34. Human antigen R mediated post-transcriptional regulation of inhibitors of apoptosis proteins in pancreatic cancer.
    Lukosiute-Urboniene A, Jasukaitiene A, Silkuniene G, Barauskas V, Gulbinas A, Dambrauskas Z.
    World J Gastroenterol; 2019 Jan 14; 25(2):205-219. PubMed ID: 30670910
    [Abstract] [Full Text] [Related]

  • 35. Decreased TIP30 expression predicts poor prognosis in pancreatic cancer patients.
    Guo S, Jing W, Hu X, Zhou X, Liu L, Zhu M, Yin F, Chen R, Zhao J, Guo Y.
    Int J Cancer; 2014 Mar 15; 134(6):1369-78. PubMed ID: 24037692
    [Abstract] [Full Text] [Related]

  • 36. Demethylation of the synuclein gamma gene CpG island in primary gastric cancers and gastric cancer cell lines.
    Yanagawa N, Tamura G, Honda T, Endoh M, Nishizuka S, Motoyama T.
    Clin Cancer Res; 2004 Apr 01; 10(7):2447-51. PubMed ID: 15073123
    [Abstract] [Full Text] [Related]

  • 37. Beclin 1 expression is an independent prognostic factor for gastric carcinomas.
    Yu M, Gou WF, Zhao S, Xiao LJ, Mao XY, Xing YN, Takahashi H, Takano Y, Zheng HC.
    Tumour Biol; 2013 Apr 01; 34(2):1071-83. PubMed ID: 23334926
    [Abstract] [Full Text] [Related]

  • 38. Role of lumican in cancer cells and adjacent stromal tissues in human pancreatic cancer.
    Ishiwata T, Cho K, Kawahara K, Yamamoto T, Fujiwara Y, Uchida E, Tajiri T, Naito Z.
    Oncol Rep; 2007 Sep 01; 18(3):537-43. PubMed ID: 17671699
    [Abstract] [Full Text] [Related]

  • 39. MicroRNA-127 is aberrantly downregulated and acted as a functional tumor suppressor in human pancreatic cancer.
    Yu Y, Liu L, Ma R, Gong H, Xu P, Wang C.
    Tumour Biol; 2016 Oct 01; 37(10):14249-14257. PubMed ID: 27571739
    [Abstract] [Full Text] [Related]

  • 40. Pathobiological implications of MUC16 expression in pancreatic cancer.
    Haridas D, Chakraborty S, Ponnusamy MP, Lakshmanan I, Rachagani S, Cruz E, Kumar S, Das S, Lele SM, Anderson JM, Wittel UA, Hollingsworth MA, Batra SK.
    PLoS One; 2011 Oct 01; 6(10):e26839. PubMed ID: 22066010
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.